Dr. Harch reviews the Chinese experience of HBOT with COVID-19 infection based on extensive communication with the treating Chinese doctors and the evolution of his presentation of this information on the internet. He discusses the different doses of HBOT, the Chinese data, the similar experience with HBOT in Spanish Flu victims in 1918, and the current HBOT COVID clinical trials registered on ClinicalTrials.gov.
